Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.

[1]  V. Margulis,et al.  Development and characterization of clinically relevant tumor models from patients with renal cell carcinoma. , 2011, European urology.

[2]  C. Ostwald,et al.  Cryopreservation of human colorectal carcinomas prior to xenografting , 2010, BMC Cancer.

[3]  M. Ychou,et al.  Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[4]  M. Hidalgo,et al.  Direct In Vivo Xenograft Tumor Model for Predicting Chemotherapeutic Drug Response in Cancer Patients , 2009, Clinical pharmacology and therapeutics.

[5]  Peter J Houghton,et al.  Establishment of human tumor xenografts in immunodeficient mice , 2007, Nature Protocols.

[6]  B. Dutrillaux,et al.  Establishment of human colon cancer cell lines from fresh tumors versus xenografts: comparison of success rate and cell line features. , 2007, Cancer research.

[7]  R. Hruban,et al.  An In vivo Platform for Translational Drug Development in Pancreatic Cancer , 2006, Clinical Cancer Research.

[8]  S. Manoir,et al.  Primary tumour genetic alterations and intra‐tumoral heterogeneity are maintained in xenografts of human colon cancers showing chromosome instability , 2006, The Journal of pathology.

[9]  E. Sausville,et al.  Contributions of human tumor xenografts to anticancer drug development. , 2006, Cancer research.

[10]  Jürgen Weitz,et al.  Colorectal cancer , 2005, The Lancet.

[11]  Emmanuel Barillot,et al.  Analysis of array CGH data: from signal ratio to gain and loss of DNA regions , 2004, Bioinform..

[12]  A. Duval,et al.  Quasimonomorphic Mononucleotide Repeats for High-Level Microsatellite Instability Analysis , 2004, Disease markers.

[13]  T. Hickish,et al.  Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. , 2004, The New England journal of medicine.

[14]  A. Sajantila,et al.  Typing of XY (male) genotype from malignant neoplastic tissue by the amelogenin-based sex test. , 2004, Journal of forensic sciences.

[15]  Xiaoen Wang,et al.  Development of a high metastatic orthotopic model of human renal cell carcinoma in nude mice: benefits of fragment implantation compared to cell-suspension injection , 1999, Clinical & Experimental Metastasis.

[16]  I. Fichtner,et al.  Anticancer drug response and expression of molecular markers in early-passage xenotransplanted colon carcinomas. , 2004, European journal of cancer.

[17]  R. James,et al.  Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial , 2000, The Lancet.

[18]  Chris Tyler-Smith,et al.  Reliability of DNA-based sex tests , 1998, Nature Genetics.

[19]  R. Hoffman,et al.  Nude mouse metastatic models of human stomach cancer constructed using orthotopic implantation of histologically intact tissue. , 1993, Cancer research.